29th Jul 2020 12:00 pm |
RNS |
2nd Quarter Results |
29th Jul 2020 7:00 am |
RNS |
Sanofi and GSK agree UK doses of COVID-19 vaccine |
28th Jul 2020 3:23 pm |
RNS |
Director/PDMR Shareholding |
24th Jul 2020 1:16 pm |
RNS |
GSK receives positive CHMP opinion for Belamaf |
20th Jul 2020 7:00 am |
RNS |
GSK and CureVac enter collaboration |
15th Jul 2020 9:31 am |
RNS |
Director/PDMR Shareholding |
15th Jul 2020 7:00 am |
RNS |
FDA Panel Votes IN FAVOR of Belantamab mafodotin |
14th Jul 2020 1:19 pm |
RNS |
Director/PDMR Shareholding |
13th Jul 2020 5:42 pm |
RNS |
Director/PDMR Shareholding |
10th Jul 2020 4:41 pm |
RNS |
Director/PDMR Shareholding |
10th Jul 2020 3:15 pm |
RNS |
Director/PDMR Shareholding |
10th Jul 2020 3:07 pm |
RNS |
Director/PDMR Shareholding |
1st Jul 2020 12:25 pm |
RNS |
Total Voting Rights |
29th Jun 2020 8:00 am |
RNS |
GSK’s daprodustat gains first regulatory approval |
19th Jun 2020 3:22 pm |
RNS |
FDA Advisory Committee review belantamab mafodotin |
18th Jun 2020 12:25 pm |
RNS |
Director/PDMR Shareholding |
16th Jun 2020 12:51 pm |
RNS |
Director/PDMR Shareholding |
11th Jun 2020 3:56 pm |
RNS |
Director/PDMR Shareholding |
9th Jun 2020 2:16 pm |
RNS |
Director/PDMR Shareholding |
1st Jun 2020 12:14 pm |
RNS |
Total Voting Rights |
29th May 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
29th May 2020 4:37 pm |
RNS |
Price Monitoring Extension |
26th May 2020 11:53 am |
RNS |
Block listing Interim Review |
19th May 2020 5:51 pm |
RNS |
Holding(s) in Company |
18th May 2020 7:09 am |
RNS |
ViiV PrEP jab shows high efficacy over daily pill |
13th May 2020 5:04 pm |
RNS |
Director/PDMR Shareholding |
11th May 2020 6:07 pm |
RNS |
Director/PDMR Shareholding |
7th May 2020 5:43 pm |
RNS |
Publication of Final Terms |
7th May 2020 3:52 pm |
RNS |
Director/PDMR Shareholding |
7th May 2020 7:56 am |
RNS |
GSK sells its holding in Hindustan Unilever |
6th May 2020 5:40 pm |
RNS |
Result of AGM |
4th May 2020 6:00 pm |
RNS |
Director/PDMR Shareholding |
4th May 2020 5:40 pm |
RNS |
Publication of a Prospectus |
4th May 2020 4:18 pm |
RNS |
Rights attached to ordinary shares |
1st May 2020 3:45 pm |
RNS |
Total Voting Rights |
30th Apr 2020 7:00 am |
RNS |
GSK’s Zejula approved in first-line ovarian cancer |
29th Apr 2020 12:00 pm |
RNS |
1st Quarter Results |
29th Apr 2020 11:00 am |
RNS |
Arrangements for Shareholder Webcast |
16th Apr 2020 3:25 pm |
RNS |
Director/PDMR Shareholding |
16th Apr 2020 2:21 pm |
RNS |
Director/PDMR Shareholding |